1. DAAs have revolutionized hepatitis C management. 
2. Mortality from cirrhosis decreased by 8.2% annually after DAAs were introduced in 2014. 
3. Non-Hispanic Black populations have shown the steepest decline in mortality rates.
4.  Men consistently had higher mortality rates than women. 
5. The analysis used CDC WONDER data. 
6. Mortality remains high among certain demographic groups, such as American Indian/Alaska Natives.

Source: AASLD